Avience Biomedicals Ltd is engaged in the trading, distribution, and marketing of pharmaceutical products, healthcare formulations, and biomedical products. The company primarily serves hospitals, healthcare institutions, pharmacies, and medical distributors across India. Its portfolio includes pharmaceutical formulations, healthcare products, and allied medical supplies sourced from reputed manufacturers. The company focuses on expanding its distribution network while maintaining product quality and regulatory compliance. Revenue is primarily generated through the sale and distribution of pharmaceutical and healthcare products. The business follows an asset-light trading model with limited manufacturing exposure. Growth depends on expanding product offerings, distribution reach, and increasing demand for healthcare products.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
24 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.